EVO

Evotec (EVO)

Evotec SE

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:EVO

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/14	21 : 30	GlobeNewswire Inc.	CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease	NASDAQ:EVO	Evotec SE
2024/04/24	20 : 29	IH Market News	Tesla Surges 12% with 2025 Affordable Vehicle Promise, Evotec Slumps 36% on Uncertain Outlook, and Latest Earnings	NASDAQ:EVO	Evotec SE
2024/04/18	20 : 27	PR Newswire (US)	EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS	NASDAQ:EVO	Evotec SE
2024/01/04	06 : 59	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVO	Evotec SE
2023/11/08	20 : 02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVO	Evotec SE
2023/11/07	15 : 30	GlobeNewswire Inc.	Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline	NASDAQ:EVO	Evotec SE
2023/08/29	22 : 59	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVO	Evotec SE
2023/07/28	20 : 41	IH Market News	Friday’s Wall Street Highlights: AMD, Intel, First Solar, Sleep Number, Roku, P&G, and more	NASDAQ:EVO	Evotec SE
2023/07/28	05 : 32	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVO	Evotec SE
2023/06/22	05 : 14	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:EVO	Evotec SE
2023/06/21	02 : 24	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:EVO	Evotec SE
2023/05/31	06 : 25	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:EVO	Evotec SE
2023/05/16	22 : 00	GlobeNewswire Inc.	Galaxy Gaming® and Evolution Extend Licensing Agreement for 10 Years	NASDAQ:EVO	Evotec SE
2023/05/15	19 : 30	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:EVO	Evotec SE
2023/05/13	06 : 32	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:EVO	Evotec SE
2023/05/13	05 : 04	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:EVO	Evotec SE
2023/05/10	05 : 38	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:EVO	Evotec SE
2023/04/07	23 : 54	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:EVO	Evotec SE
2023/03/28	23 : 28	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:EVO	Evotec SE
2023/03/28	23 : 13	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:EVO	Evotec SE
2023/02/03	03 : 25	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:EVO	Evotec SE
2022/11/16	20 : 04	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:EVO	Evotec SE
2022/11/09	20 : 05	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:EVO	Evotec SE
2022/10/17	20 : 00	Business Wire	TIAP and Evotec Expand LAB150 BRIDGE Partnership to Include Amgen	NASDAQ:EVO	Evotec SE
2022/08/11	19 : 06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:EVO	Evotec SE
2022/08/10	14 : 30	Business Wire	Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303	NASDAQ:EVO	Evotec SE
2022/06/24	00 : 01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:EVO	Evotec SE
2022/06/09	19 : 05	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:EVO	Evotec SE
2022/06/08	00 : 37	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:EVO	Evotec SE
2022/04/12	21 : 16	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:EVO	Evotec SE